FDA approves Biogen’s Alzheimer’s drug, the first to slow the disease
June 07, 2021 at 11:59 AM EDT
The first drug promising to slow the memory-robbing march of Alzheimer’s disease was approved by U.S. health regulators, a watershed after years of research and billions of dollars in investment.